HIV maturation inhibitor - ViiV Healthcare (GSK)

HIV maturation inhibitor

Ph. II candidate for HIV

from prior clinical candidate

Antimicrob. Agents Chemother.

ViiV Healthcare (GSK)

GSK3640254 is an HIV maturation inhibitor and Ph. IIb clinical candidate (60-180 mg PO QD) with activity against a range of HIV strains with Gag polymorphisms. The first HIV…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.